BioLight Engineering LLC (BEL) develops portable, non-mydriatic ultra-widefield fundus cameras for pediatric retinal examination.
BioLight is developing a family of portable, non-mydriatic ultra-widefield fundus cameras — a dedicated handheld camera (PedCam) and a smartphone-based system (PedCam-SP) — both investigational and under active development.
BioLight Engineering LLC’s mission is to develop, validate, and commercialize innovative ophthalmic imaging technologies that are affordable, clinically effective, and practical for use in diverse healthcare settings. By combining advanced optical engineering with clinician-centered design, we seek to improve the early detection, diagnosis, and management of retinal diseases and help prevent avoidable vision loss.
A central focus of our mission is expanding access to retinal examinations for infants and children, particularly in communities where specialized eye care and conventional imaging systems are limited or unavailable. We are developing portable, easy-to-use, nonmydriatic ultra-widefield retinal imaging technology that can be deployed wherever care is needed, including hospitals, neonatal units, community clinics, mobile screening programs, and underserved regions.
Through close collaboration with clinicians, researchers, healthcare organizations, and community partners, BioLight Engineering aims to translate optical innovations into scalable clinical solutions that simplify retinal screening, support timely treatment decisions, and improve eye health outcomes worldwide.
BioLight Engineering LLC envisions a future in which advanced eye care is accessible to every community, regardless of geography, income, or healthcare infrastructure. Our goal is to transform retinal screening through affordable, clinically effective, and easy-to-use optical imaging technologies that enable earlier diagnosis, timely treatment, and long-term preservation of vision.
We are particularly committed to preventing avoidable childhood blindness. No child should lose vision because a treatable eye condition was not detected early enough or because appropriate imaging technology was unavailable. By developing portable, nonmydriatic ultra-widefield retinal cameras, BioLight Engineering seeks to streamline eye examinations and expand screening beyond specialized ophthalmology centers to community clinics, neonatal units, mobile health programs, and other underserved settings.
Through innovation, clinical collaboration, and scalable technology, we aim to reduce barriers to retinal imaging, support healthcare professionals in making timely and informed decisions, and improve eye health outcomes worldwide.
Our work brings together industry, engineering, and clinical medicine through three collaborating partners.
The company translating federally funded optical research into portable, non-mydriatic imaging devices.
The Department of Biomedical Engineering at the University of Illinois Chicago, driving device design and engineering.
Clinical partners in ophthalmology guiding real-world validation and pediatric application.
For inquiries about our development program, research collaboration, or federal funding record, please reach out.